Novel peptides suppress VEGFR-3 activity and antagonize VEGFR-3-mediated oncogenic effects

Vascular endothelial growth factor receptor 3 (VEGFR-3) supports tumor lymphangiogenesis. It was originally identified as a lymphangiogenic factor expressed in lymphatic endothelial cells. VEGFR-3 was detected in advanced human malignancies and correlated with poor prognosis. Our previous studies sh...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Yi-Wen, Su, Chih-Ming, Su, Yen-Hao, Ho, Yuan-Soon, Lai, Hui-Huang, Chen, Hsin-An, Kuo, Min-Liang, Hung, Wen-Chun, Chen, Ya-Wen, Wu, Chih-Hsiung, Chen, Pai-Sheng, Su, Jen-Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4116523/
https://www.ncbi.nlm.nih.gov/pubmed/25003617

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4116523/
https://www.ncbi.nlm.nih.gov/pubmed/25003617

Ejemplares similares